Search

Author/Creator Jonasch, E.

1. Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis. (November 2018)

Authors:
Campbell, Matthew T.; Bilen, Mehmet A.; Shah, Amishi Y.; Lemke, Emily; Jonasch, E.; Venkatesan, A.M.; Altinmakas, E.; Duran, C.; Msaouel, Pavlos; Tannir, N.M.
Journal:
European journal of cancer
Issue:
Volume 104(2018)
Page Start:
188
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors. (June 2019)

Authors:
Shah, A.Y.; Kotecha, R.R.; Lemke, E.A.; Chandramohan, A.; Chaim, J.L.; Msaouel, P.; Xiao, L.; Gao, J.; Campbell, M.T.; Zurita, A.J.; Wang, J.; Corn, P.G.; Jonasch, E.; Motzer, R.J.; Sharma, P.; Voss, M.H.; Tannir, N.M.
Journal:
European journal of cancer
Issue:
Volume 114(2019)
Page Start:
67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search